ATE332928T1 - Triblockpolymere für arzneistoff- oder genzufuhr auf nanokugelbasis - Google Patents

Triblockpolymere für arzneistoff- oder genzufuhr auf nanokugelbasis

Info

Publication number
ATE332928T1
ATE332928T1 AT03808379T AT03808379T ATE332928T1 AT E332928 T1 ATE332928 T1 AT E332928T1 AT 03808379 T AT03808379 T AT 03808379T AT 03808379 T AT03808379 T AT 03808379T AT E332928 T1 ATE332928 T1 AT E332928T1
Authority
AT
Austria
Prior art keywords
ananoball
based medicine
triblock polymers
delivery
genuine
Prior art date
Application number
AT03808379T
Other languages
English (en)
Inventor
Joachim Kohn
Corinne Vebert-Nardin
Durgadas Bolikal
Agnieszka Seyda
Original Assignee
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rutgers filed Critical Univ Rutgers
Application granted granted Critical
Publication of ATE332928T1 publication Critical patent/ATE332928T1/de

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03808379T 2002-05-15 2003-05-15 Triblockpolymere für arzneistoff- oder genzufuhr auf nanokugelbasis ATE332928T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37804202P 2002-05-15 2002-05-15

Publications (1)

Publication Number Publication Date
ATE332928T1 true ATE332928T1 (de) 2006-08-15

Family

ID=32230079

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03808379T ATE332928T1 (de) 2002-05-15 2003-05-15 Triblockpolymere für arzneistoff- oder genzufuhr auf nanokugelbasis

Country Status (7)

Country Link
EP (1) EP1504046B1 (de)
AT (1) ATE332928T1 (de)
AU (1) AU2003301690B2 (de)
CA (1) CA2486104C (de)
DE (1) DE60306769T2 (de)
ES (1) ES2270171T3 (de)
WO (1) WO2004039944A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060177416A1 (en) 2003-10-14 2006-08-10 Medivas, Llc Polymer particle delivery compositions and methods of use
US8591951B2 (en) * 2002-05-15 2013-11-26 Joachim B. Kohn Tri-block copolymers for nanosphere-based drug delivery
EP1848410A4 (de) * 2005-02-17 2011-11-09 Medivas Llc Zusammensetzungen zur ausgabe von polymerteilchen und anwendungsverfahren dafür
WO2007038246A2 (en) 2005-09-22 2007-04-05 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
US8445007B2 (en) 2005-09-22 2013-05-21 Medivas, Llc Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use
US20070134332A1 (en) * 2005-11-21 2007-06-14 Medivas, Llc Polymer particles for delivery of macromolecules and methods of use
CA2777234C (en) 2009-10-11 2019-02-26 Rutgers, The State University Of New Jersey Biocompatible polymers for medical devices
JP6045575B2 (ja) 2011-06-23 2016-12-14 ディーエスエム アイピー アセッツ ビー.ブイ. 薬物送達のための新規な生分解性ポリエステルアミドコポリマー
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
US11472918B2 (en) 2012-02-03 2022-10-18 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses
EP3312155B1 (de) 2012-02-03 2020-08-05 Rutgers, The State University of New Jersey Polymere biomaterialien aus phenolischen monomeren und deren medizinische verwendungen
US10434071B2 (en) 2014-12-18 2019-10-08 Dsm Ip Assets, B.V. Drug delivery system for delivery of acid sensitivity drugs
US10774030B2 (en) 2014-12-23 2020-09-15 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587507A (en) * 1995-03-31 1996-12-24 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
US6319492B1 (en) * 1996-11-27 2001-11-20 Rutgers, The State University Copolymers of tyrosine-based polyarylates and poly(alkylene oxides)
KR20010020536A (ko) * 1997-06-27 2001-03-15 인테그라 라이프사이언시스 아이, 리미티드 이상 중합 방법
US6103255A (en) * 1999-04-16 2000-08-15 Rutgers, The State University Porous polymer scaffolds for tissue engineering

Also Published As

Publication number Publication date
CA2486104C (en) 2014-07-29
DE60306769T2 (de) 2006-11-16
EP1504046A4 (de) 2005-09-21
EP1504046A2 (de) 2005-02-09
ES2270171T3 (es) 2007-04-01
AU2003301690B2 (en) 2009-08-13
AU2003301690A1 (en) 2004-05-25
WO2004039944A2 (en) 2004-05-13
CA2486104A1 (en) 2004-05-13
WO2004039944A3 (en) 2004-07-01
DE60306769D1 (de) 2006-08-24
EP1504046B1 (de) 2006-07-12

Similar Documents

Publication Publication Date Title
ATE332928T1 (de) Triblockpolymere für arzneistoff- oder genzufuhr auf nanokugelbasis
WO2007018544A3 (en) Tri-block copolymers for nanosphere-based drug delivery
ATE317711T1 (de) Elektropolymerisierbare monomere und polymerbeschichtungen auf implantierbaren geräten
MXPA02012601A (es) Polimeros radicales cationicos o anfotericos autoadhesivos y su uso en cosmeticos.
ATE288956T1 (de) Verwendung eines amphoteren polymeres zur behandlung ausgewählter harter oberflächen
TW200631604A (en) Ophthalmic compositions comprising polyether substituted polymers
WO2001048190A3 (en) Therapeutic uses of lna-modified oligonucleotides
WO2004009664A3 (en) Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from
DE602004022834D1 (de) Biologisch absorbierbare überzüge für implantierbare vorrichtungen
WO2007124132A2 (en) Polymeric compositions and methods of making and using thereof
CA2308721A1 (en) Radio-opaque polymer biomaterials
DE60028415D1 (de) Methode und zusammensetzungen für verbesserte abgabevorrichtungen
WO2008082738A3 (en) N-substituted monomers and polymers
EP1196149A4 (de) IN ORGANISCHEN LÖSEMITTELN LÖSLICHE BIOLOGISCH ABBAUBARE POLY (ALKYLENOXID)- POLY (p-DIOXANON) BLOCKCOPOLYMERE SOWIE DIESE ENTHALTENDE ZUSAMMENSETZUNG ZUR ARZNEISTOFFVERABREICHUNG
WO2002039948A3 (en) Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants
ATE460437T1 (de) Polymere von fluormonomeren und hydrophilen monomeren
GB9814609D0 (en) Polymers
BR0214136A (pt) Polìmeros de enxerto, processo para a preparação e uso dos mesmos
DE60334388D1 (de) Blockcopolymer-mizellenzusammensetzung mit verbesserter arzneimittelbeladungskapazität und verzögerter freisetzung
GB2451599A (en) Nanostructures suitable for delivery of agents
DE602004025210D1 (de) Azlacton-photoiniferter für die radikalische polymerisation
WO2006044795A3 (en) Electrochemically degradable polymers
IL177777A0 (en) Polymer particles containing active agents
TW200613012A (en) Sustained-release composition, process for producing the same and use of the same
AUPR412801A0 (en) Agent for the prevention and treatment of sexually transmitted disease s - I

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties